GI Bleeding Higher in Pradaxa vs. Warfarin
The prescription blood-thinners Pradaxa (dabigatran) and warfarin aim to reduce stroke and other cardiovascular disorders, but like most medications, they do carry some risks.
FDA Compares Risks of Pradaxa and Warfarin
FDA research has taken a closer look at the risks of two medications commonly used to lower the risk for stroke and blood clots.
Blood Thinners Recommended for AFib Patients
People with atrial fibrillation, a common heart rhythm disorder, face a high likelihood of stroke. To reduce the risk, the American Academy of Neurology recommends taking anticoagulants.
Blood Thinners: To Continue or Not
Blood thinners are a mixed blessing for patients. On one hand, they can prevent strokes. But on the other, they can cause serious bleeding during surgery.
Does Stroke Rx Cause Excess Bleeding?
People with abnormal heart rhythms are at a higher risk of getting blood clots, which can cause a stroke. A blood-thinning medication may help. But some questions remain if these medications cause the bleeding.
Newer Blood Thinner Gaining Affirmation
Patients with atrial fibrillation, a common heart arrhythmia, have a higher risk of experiencing a stroke or blood clots. Warfarin (Coumadin) has long been the gold standard in treatment. That could be changing.
Clot Busters Safe for Warfarin Patients
After a stroke, tPA (tissue plasminogen activator), also known as a clot buster, offers the most effective acute treatment.
Women with Arrhythmia at Greater Stroke Risk
Women with a common abnormal heartbeat condition called atrial fibrillation are at a greater risk of stroke even if they take anticoagulants to lower their risk. This was especially true for women over the age of 75.
Risk High During Temporary Anticoagulant Halts
Patients with certain types of atrial fibrillation, a common heart arrhythmia, are at a high risk of stroke and blood clots if they temporarily stop their blood thinning medication before surgery or permanently because of side effects.
New Arrhythmia Drug Boasts Lower Brain Bleeding
Prior to its approval last year, there was much debate about Xarelto ( rivaroxaban ), an anti-clotting drug designed to prevent stroke among patients with atrial fibrillation, a common heart arrhythmia.